SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Bleyer A. Latest estimates of survival rates of the 24 most common cancers in adolescent and young adult Americans. J Adolesc Young Adult Oncol. 2011;1:37-42.
  • 2
    Bellizzi KM, Aziz NM, Rowland JH, et al. Double jeopardy? Age, race, and HRQOL in older adults with cancer. J Cancer Epidemiol. 2012;2012:478642.
  • 3
    Avis NE, Deimling GT. Cancer survivorship and aging. Cancer. 2008;113:3519-3529.
  • 4
    Kazak AE, Derosa BW, Schwartz LA, et al. Psychological outcomes and health beliefs in adolescent and young adult survivors of childhood cancer and controls. J Clin Oncol. 2010;28:2002-2007.
  • 5
    Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572-1582.
  • 6
    Casillas J, Syrjala KL, Ganz PA, et al. How confident are young adult cancer survivors in managing their survivorship care? A report from the LIVESTRONG Survivorship Center of Excellence Network. J Cancer Surviv. 2011;5:371-381.
  • 7
    Zebrack B. Information and service needs for young adult cancer survivors. Supportive Care Cancer. 2009;17:349-357.
  • 8
    Bellizzi KM, Smith A, Schmidt S, et al. Positive and negative psychosocial impact of being diagnosed with cancer as an adolescent or young adult. Cancer. 2012;118:5155-5162.
  • 9
    Gorman JR, Malcarne VL, Roesch SC, Madlensky L, Pierce JP. Depressive symptoms among young breast cancer survivors: the importance of reproductive concerns. Breast Cancer Res Treat. 2010;123:477-485.
  • 10
    Smith AW, Bellizzi KM, Keegan THM, et al. Health-related quality of life of adolescent and young adult cancer patients in the United States: the AYA HOPE study. J Clin Oncol. 2013;31:2136-2145.
  • 11
    Rowland JH. Developmental stage and adaptation: adult model. In: Holland JC, Rowland JH, eds. Handbook of Psychooncology. New York: Oxford University Press; 1990:25-43.
  • 12
    Zebrack BJ. Psychological, social, and behavioral issues for young adults with cancer. Cancer. 2011;117:2289-2294.
  • 13
    National Cancer Institute, LIVESTRONG Young Adult Alliance. Closing the Gap: A Strategic Plan. Addressing the recommendations of the Adolescent and Young Adult Oncology Progress Review Group. http://planning.cancer.gov/library/2007_ayao_SP.pdf. Accessed October 29, 2012.
  • 14
    Hewitt M, Greenfield S, Stovall E, eds.; Institute of Medicine, National Research Council. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: National Academies Press; 2006.
  • 15
    Stanton AL. What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol. 2012;30:1215-1220.
  • 16
    Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res. 1995;4:523-531.
  • 17
    Kwak M, Zebrack BJ, Meeske KA, et al. Trajectories of psychological distress in adolescent and young adult patients with cancer: a 1-year longitudinal study. J Clin Oncol. 2013;31:2160-2166.
  • 18
    Cella D, Riley W, Stone A, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010;63:1179-1194.
  • 19
    Gershon R, Lai J, Bode R, et al. Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing. Qual Life Res. 2012;21:475-486.
  • 20
    Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103:117-128.
  • 21
    Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-655.
  • 22
    Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570-579.
  • 23
    Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D. Measuring spiritual well-being in people with cancer: The Functional Assessment of Chronic Illness Therapy–Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med. 2002;24:49-58.
  • 24
    Cella D, Zagari MJ, Vandoros C, Gagnon DD, Hurtz HJ, Nortier JW. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. J Clin Oncol. 2003;21:366-373.
  • 25
    Bredle JM, Salsman JM, Debb SM, Arnold BJ, Cella D. Spiritual well-being as a component of health-related quality of life: The Functional Assessment of Chronic Illness Therapy—Spiritual Well-Being Scale (FACIT-Sp). Religions. 2011;2:77-94.
  • 26
    Veit CT, Ware JE Jr. The structure of psychological distress and well-being in general populations. J Consult Clin Psychol. 1983;51:730-742.
  • 27
    Tedeschi RG, Calhoun LG. The Post-traumatic Growth Inventory: Measuring the positive legacy of trauma. J Trauma Stress. 1996;9:455-471.
  • 28
    Cann A, Calhoun LG, Tedeschi RG, et al. A short form of the Posttraumatic Growth Inventory. Anxiety Stress Coping. 2010;23:127-137.
  • 29
    Andrykowski MA, Bishop M, Hahn EA, et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol. 2005;23:599-608.
  • 30
    Lai JS, Garcia SF, Salsman JM, Rosenbloom S, Cella D. The psychosocial impact of cancer: evidence in support of independent general positive and negative components. Qual Life Res. 2012;21:195-207.
  • 31
    Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2009_pops09/. Based on November 2011 SEER data submission, posted to the SEER web site, April 2012.
  • 32
    Yost KJ, Sorensen MV, Hahn EA, Glendenning GA, Gnanasakthy A, Cella D. Using multiple anchor-and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) Instrument. Value Health. 2005;8:117-127.
  • 33
    Yost KJ, Eton DT. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Eval Health Prof. 2005;28:172-191.
  • 34
    Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112:2577-2592.
  • 35
    Park CL, Folkman S. Meaning in the context of stress and coping. Rev Gen Psychol. 1997;1:115-144.
  • 36
    Helgeson VS, Reynolds KA, Tomich PL. A meta-analytic review of benefit finding and growth. J Consult Clin Psychol. 2006;74:797-816.
  • 37
    Tai E, Buchanan N, Townsend J, Fairley T, Moore A, Richardson LC. Health status of adolescent and young adult cancer survivors. Cancer. 2012;118:4884-4891.
  • 38
    Jacobsen PB. Present and Future Research for Survivorship. In: American Psychosocial Oncology Society 8th Annual Conference. Anaheim, CA; February 17-19, 2011.
  • 39
    Liu H, Cella D, Gershon R, et al. Representativeness of the PROMIS Internet Panel. J Clin Epidemiol. 2010;63:1169-1178.
  • 40
    American College of Surgeons, Commission on Cancer. Cancer Program Standards 2012: Ensuring Patient-Centered Care. Chicago, IL: American College of Surgeons; 2012.